论文部分内容阅读
目的 :探讨心血管疾病联合用药、不良反应以及合理用药分析。方法 :将2012年3月至2015年2月期间我院收治的50例心血管疾病患者作为本次研究对象,对所有患者的用药情况进行分析,采用合理用药系统进行监测,分析不良反应发生原因,并探讨其合理用药原则。结果:合理用药后,心血管疾病患者的不良反应发生率为10.00%,较合理用药前的44.00%明显更低(P<0.05)。结论 :临床医生应对心血管疾病患者联合用药问题给予重视,做到合理用药,剂量适中,降低不良反应发生率。
Objective: To investigate the combination of cardiovascular disease, adverse reactions and rational use of drugs analysis. Methods: From March 2012 to February 2015 in our hospital for treatment of 50 cases of cardiovascular disease patients as the object of this study, all patients were analyzed for drug use, the use of rational drug delivery system for monitoring and analysis of the causes of adverse reactions , And explore its principle of rational use of drugs. Results: After the rational use of drugs, the incidence of adverse reactions in patients with cardiovascular diseases was 10.00%, significantly lower than 44.00% before the rational use of drugs (P <0.05). Conclusions: Clinicians should pay more attention to the combination therapy of patients with cardiovascular diseases, so that they can be used rationally and moderately and reduce the incidence of adverse reactions.